Source: The Insides Company Limited
On: 9:00am Auckland, Monday 20th April 2020
Companies: The Insides Company Limited
The Insides Company is delighted to announce the recent publication of the article, “Novel chyme reinfusion device for gastrointestinal fistulas and stomas: feasibility study” under the British Journal of Surgery (BJS), featuring the company’s therapeutic chyme reinfusion solution for the management of high-output enteroatmospheric fistulas and high-output ileostomies, The InsidesTM Systemfi.
The British Journal of Surgery (BJS) is a prestigious peer-reviewed publication for general surgeons and associated subspecialties. With an impact factor of 5.899, it ranks as top general surgical journal across Europe.
The Insides Company would like to congratulate Puja Sharma, Professor Ian Bisset, Associate Greg O’Grady and the rest of the team involved in the feasibility study. This publication marks an important milestone in validating the therapeutic benefits of our medical device solution. The company is dedicated to continuing its contribution in improving the outcomes of patients with high-output enteroatmospheric fistulas and high-output ileostomies.
About the Insides Company
The Insides Company Limited is a medical device company, spun out form the University of Auckland. The company is a leading provider of therapeutic Chyme Reinfusion solutions for the management of High-Output Enteroatmospheric Fistulas and High-Output Ileostomies.
CEO, The Insides Company
Ph: +64 98879309, +44 2033896331, +1 6507580037